AGÕæÈ˹ٷ½

STOCK TITAN

Centrus Energy SEC Filings

LEU NYSE

Welcome to our dedicated page for Centrus Energy SEC filings (Ticker: LEU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking Centrus Energy’s progress on restoring domestic uranium enrichment shouldn’t require a Ph.D. in nuclear engineering. Yet each 300-page disclosure is packed with centrifuge performance data, HALEU milestones, and government cost-share details that investors can’t afford to miss. That’s why our page puts Centrus Energy SEC filings explained simply front-and-center.

Use Stock Titan’s AI to turn dense documents into clear takeaways: the Centrus Energy annual report 10-K simplified pinpoints long-term LEU contracts and Oak Ridge deployment costs; every Centrus Energy quarterly earnings report 10-Q filing is summarized so you can compare separative-work revenue quarter-over-quarter; and our alerts flag Centrus Energy 8-K material events explained—from new DOE awards to unexpected production pauses. AGÕæÈ˹ٷ½-time crawlers capture Centrus Energy Form 4 insider transactions real-time, letting you spot executive stock moves minutes after they hit EDGAR.

Whether you need a quick view of Centrus Energy insider trading Form 4 transactions, deeper Centrus Energy earnings report filing analysis, or clarity on the Centrus Energy proxy statement executive compensation plan that ties bonuses to HALEU deliverables, our platform has you covered. Interactive highlights, side-by-side comparisons, and AI-powered plain-English summaries mean understanding Centrus Energy SEC documents with AI is finally practical. Save hours, monitor risk, and make informed nuclear-energy decisions—without sifting through reams of technical jargon.

Rhea-AI Summary

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc. and Steven A. Cohen jointly filed a Schedule 13G disclosing passive ownership of 588,632 shares of Avalo Therapeutics, Inc. (AVTX) as of 4 Aug 2025. The position represents 5.4 % of the company’s outstanding common stock, meeting the threshold that requires beneficial-ownership disclosure under Section 13(d) of the Exchange Act.

The shares are held by Point72 Associates, an investment fund managed by Point72 Asset Management. All three reporting persons share voting and dispositive power; none claim sole authority. The filing states the stake is not intended to influence control of Avalo and is classified as a passive investment (Rule 13d-1(c)). Signatures were executed by authorized person Jason M. Colombo on 5 Aug 2025. An Exhibit 99.1 Joint Filing Agreement is included.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
current report
-
Filing
Rhea-AI Summary

Form 144 Filing Snapshot: Centrus Energy Corp. (NYSE: LEU) has submitted a Form 144 indicating a planned sale of up to 5,949 common shares on or around 15 July 2025. The broker of record is Citigroup Global Markets Inc.

Monetary Value & Scale: Based on the filing’s reference price, the proposed transaction totals roughly $1.27 million, compared with the company’s 16.32 million shares outstanding. The position represents just 0.036 % of total shares, suggesting limited supply impact.

Source of Shares: The stock originates from restricted-stock units that vest on the same date, classifying the sale as compensation-related liquidity rather than a discretionary reduction in ownership.

Market Context: No insider sales have been reported during the previous three months, and the filer affirms awareness of no undisclosed material adverse information. Transactions will occur on the NYSE.

Investor Takeaway: Given the modest size and routine nature of the filing, the event is unlikely to influence Centrus Energy’s valuation or trading dynamics in a material way.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Centrus Energy Corp (NYSE: LEU) has announced a significant milestone in its nuclear fuel production contract with the U.S. Department of Energy. The company's subsidiary, American Centrifuge Operating, has successfully completed Phase II of its contract by producing and delivering 900 kilograms of High-Assay, Low-Enriched Uranium (HALEU).

Key developments include:

  • Total HALEU production has exceeded 920 kilograms to date under the DOE contract
  • Company has now advanced to Phase III of the contract
  • Achievement demonstrates Centrus's capability in producing advanced nuclear fuel

This development is particularly significant as HALEU is a crucial fuel for next-generation nuclear reactors. The successful completion of Phase II production targets positions Centrus as a key player in the domestic nuclear fuel supply chain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.72%
Tags
current report
Rhea-AI Summary

Director Ray A. Rothrock reported multiple transactions in Centrus Energy Corp (LEU) stock on June 20, 2025:

  • Acquired 684 shares of Class A Common Stock at $0 as part of equity compensation
  • Disposed of 1,575 shares through share surrender to cover tax obligations from 2024 RSU settlement
  • Following these transactions, Rothrock directly owns 2,158 shares of Class A Common Stock

The newly acquired restricted stock units (RSUs) will vest on June 18, 2026. The filing includes 3,049 shares of Class A Common Stock granted under the company's equity incentive plan. The Form 4 was filed by attorney-in-fact Shahram Ghasemian on June 24, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 filing reveals insider trading activity for Donald Kirkland H, Director at Centrus Energy Corp (NYSE: LEU). On June 20, 2025, two significant transactions occurred:

  • Acquired 684 Class A Common Stock shares through Restricted Stock Units (RSUs) at $0
  • Disposed of 1,318 shares through share surrender to cover tax obligations from 2024 RSU settlement

Following these transactions, Kirkland's direct beneficial ownership stands at 8,231 shares, which includes 2,786 vested RSUs and 6,079 Class A common stock under the company's equity incentive plan. The newly granted RSUs will vest on June 18, 2026. The filing was submitted by attorney-in-fact Shahram Ghasemian on June 24, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 Overview â€� On 06/20/2025 Centrus Energy Corp. (LEU) director William J. Madia reported two transactions involving Class A common stock.

The insider acquired 684 shares coded “A,� reflecting the receipt of restricted stock units (RSUs) granted under the company’s equity incentive plan at a stated price of $0. He simultaneously disposed of 1,575 shares coded “F,� representing shares surrendered to the company to cover withholding taxes upon the settlement of prior-year RSUs. After these moves, Madia’s direct beneficial ownership stands at 57,031 shares, comprised of 47,445 vested RSUs and 10,477 common shares.

The newly granted RSUs will vest on 06/18/2026 and be settled in shares at that time. No derivative securities were reported. The filing is routine, with a modest net decrease of 891 shares and no cash proceeds, and is unlikely to materially affect LEU’s valuation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Bradley J. Sawatzke, Director of Centrus Energy Corp (NYSE: LEU), reported a significant insider transaction on June 20, 2025. The filing discloses that Sawatzke surrendered 2,734 shares of Class A Common Stock to the company in a tax liability-related transaction.

The shares were surrendered at $0 price to satisfy tax obligations associated with the settlement of previously awarded 2024 and 2021 Restricted Stock Units (RSUs). Following this transaction, Sawatzke maintains direct beneficial ownership of 5,949 shares of Class A Common Stock.

This Form 4 filing, executed by attorney-in-fact Shahram Ghasemian, represents a routine tax withholding event rather than an open market transaction, indicating no change in the director's investment outlook. The transaction was processed under transaction code 'F', which typically denotes a payment of exercise price or tax liability by delivering or withholding securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Centrus Energy Corp (LEU) Director Mikel H Williams reported changes in beneficial ownership through two transactions on June 20, 2025:

  • Acquired 684 Class A Common Stock shares through restricted stock units (RSUs) at $0
  • Disposed of 1,713 shares through share surrender to cover tax obligations related to 2024 RSU settlement

Following these transactions, Williams beneficially owns 51,779 shares directly, which includes 47,445 vested RSUs and 5,363 shares from the company's equity incentive plan. The newly granted RSUs will vest on June 18, 2026. The Form 4 was filed by attorney-in-fact Shahram Ghasemian on June 24, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Centrus Energy Corp (LEU) Director Stephanie L. O'Sullivan reported multiple transactions in Class A Common Stock on June 20, 2025:

  • Acquisition: Received 684 shares at $0 (granted as restricted stock units)
  • Disposition: Surrendered 1,168 shares to cover tax obligations from 2024 RSU settlement
  • Final Position: 2,672 shares held directly

The newly acquired restricted stock units will vest on June 18, 2026. The total beneficial ownership includes 3,156 shares from the company's equity incentive plan. This Form 4 filing was submitted by attorney-in-fact Shahram Ghasemian on June 24, 2025, reporting changes in beneficial ownership pursuant to Section 16(a) of the Securities Exchange Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

On 18 June 2025, Omnicell, Inc. (OMCL) filed a Form S-8 to register 1,750,000 additional common shares for issuance under the company’s 2009 Equity Incentive Plan (as amended). The submission references ten earlier S-8 filings dating back to 2009 and incorporates by reference the company’s latest Form 10-K, Form 10-Q and several Form 8-Ks. Customary exhibits—legal opinion, auditor consent, filing-fee table and power of attorney—are included.

This is an administrative capital-markets filing; no new operating or financial data are provided. The registration expands the share reserve available for future equity awards to employees, officers and directors, supporting Omnicell’s long-term compensation strategy. While the move does not immediately change the share count, the issuance and eventual vesting of these awards may create modest dilution for existing shareholders.

  • Shares registered: 1,750,000
  • Plan affected: Omnicell, Inc. 2009 Equity Incentive Plan
  • Principal executive offices: 4220 North Freeway, Fort Worth, TX 76137
  • Legal counsel: Foley & Lardner LLP
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Centrus Energy (LEU)?

The current stock price of Centrus Energy (LEU) is $213.8 as of August 5, 2025.

What is the market cap of Centrus Energy (LEU)?

The market cap of Centrus Energy (LEU) is approximately 3.5B.

What is the core business of Centrus Energy?

Centrus Energy specializes in supplying nuclear fuel, particularly low enriched uranium (LEU) and high assay low-enriched uranium (HALEU), using advanced American centrifuge technology, while also offering engineering and technical services.

How does Centrus Energy generate revenue?

The company generates revenue through its LEU segment by processing and selling separative work units and uranium, as well as through its Technical Solutions segment that provides design, engineering, and manufacturing services to government and commercial clients.

What role does centrifuge technology play in its operations?

Centrifuge technology is central to Centrus' operations, enabling the efficient separation of uranium isotopes. This advanced method not only supports the production of LEU and HALEU but also reinforces the company’s commitment to using American-made technology.

How does Centrus Energy contribute to domestic energy security?

By deploying state-of-the-art, American-made centrifuge technology and establishing partnerships with federal agencies, Centrus Energy is pivotal in restoring domestic uranium enrichment capabilities, thus bolstering U.S. energy security and reducing dependency on foreign sources.

What distinguishes Centrus Energy from its competitors?

Centrus is the only publicly traded, U.S.-owned company that focuses exclusively on enrichment technologies based on American designs. Its established track record in meeting long-term contracts and its integration with public-private initiatives set it apart in a competitive industry.

What are the primary market segments that Centrus serves?

The company primarily serves the nuclear power industry by providing fuel for commercial reactors and advanced reactor designs, while also offering technical solutions to government and private sector clients involved in nuclear energy.

How does Centrus Energy manage quality and delivery reliability?

Centrus maintains strict quality control processes and adheres to long-term contractual commitments, ensuring on-time deliveries and meeting stringent specifications mandated by utility customers in the nuclear industry.

What are the benefits of the company's public-private partnership model?

This model enables a collaborative approach to funding and innovation, ensuring a robust domestic supply chain for nuclear fuel. It combines federal support with private investments, which is critical for scaling operations and advancing technological capabilities.
Centrus Energy

NYSE:LEU

LEU Rankings

LEU Stock Data

3.55B
15.53M
4.83%
77.25%
16.36%
Uranium
Mining & Quarrying of Nonmetallic Minerals (no Fuels)
United States
BETHESDA